Effect of chronic treatment with the protein kinase C inhibitor staurosporine on the acquisition and expression of contextual fear conditioning

Eur J Pharmacol. 2002 Apr 26;441(3):151-5. doi: 10.1016/s0014-2999(02)01441-3.

Abstract

The present study investigated the effects of acute and chronic administration of the protein kinase C inhibitor, staurosporine, on the acquisition and expression of conditioned freezing behavior, an index of anxiety induced by conditioned fear stress. Results revealed that acute staurosporine (0.01 and 0.1 mg/kg, i.p.) did not affect either acquisition or expression of conditioned freezing. Chronic staurosporine administration (0.01 or 0.1 mg/kg, i.p., for 14 days) significantly reduced the acquisition of conditioned freezing at a dose of 0.1 mg/kg, but failed to affect the expression of conditioned freezing at any dose. These results suggest the involvement of protein kinase C in synaptic and cellular plasticity underlying emotional learning and memory.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier Proteins / administration & dosage*
  • Conditioning, Psychological / drug effects*
  • Conditioning, Psychological / physiology
  • Dose-Response Relationship, Drug
  • Fear / drug effects*
  • Fear / physiology
  • Intracellular Signaling Peptides and Proteins*
  • Male
  • Pain Measurement / drug effects
  • Protein Kinase C / antagonists & inhibitors*
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Staurosporine / administration & dosage*

Substances

  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • protein kinase modulator
  • Protein Kinase C
  • Staurosporine